Cabozantinib significantly reduced disease progression risk in patients with advanced neuroendocrine tumors: A 62% lower risk in extrapancreatic NETs and 77% in pancreatic NETs, study authors report.
An article explores the repercussions of proposed Medicaid cuts by U.S. House Republicans in California, revealing personal struggles and opposition to the potential changes.
February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.
These guidelines represent a comprehensive update to the 2014 recommendations, developed following a thorough literature review and consensus among experts from the three major GI societies.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Randomized trial shows twice-daily supplementation improves quality of life, reduces inflammation markers, and lessens symptom severity in patients with mild to moderate disease.
Researchers found that children with functional gastrointestinal disorders experience higher school absenteeism than those with organic diseases, suggesting absenteeism could provide diagnostic insight.
Researchers found that universal hepatitis C screening guidelines increased testing rates in pregnant women, but overall uptake remained low, particularly among nonpregnant women.
Short-term overeating triggers liver fat accumulation and disrupts brain insulin action in healthy-weight men, with effects persisting after returning to a normal diet.